Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine - PubMed (original) (raw)
Comparative Study
doi: 10.1681/ASN.2005020183. Epub 2006 Jul 12.
Affiliations
- PMID: 16837634
- DOI: 10.1681/ASN.2005020183
Comparative Study
Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine
Alexander M Walker et al. J Am Soc Nephrol. 2006 Aug.
Abstract
Patients with anemia and patients with chronic kidney disease have elevated risks for cardiovascular disease. Available studies have been too small to provide details about the relationship or to provide for extensive covariate control. In a large insurance database with linked laboratory values, records of women with serum creatinine >1.2 mg/dl and men with serum creatinine >1.4 mg/dl, identified from July 2000 through June 2003, were sought, and the insurance claims searches for hospitalizations that were associated with myocardial infarction, coronary revascularization, unstable angina, stroke, or congestive heart failure. New onset of dialysis also was sought. Multivariate Poisson regression was used to estimate rate ratios for these events at various hemoglobin (Hb) levels, with adjustment for patient characteristics and previous event history. Among 88,657 patients with high serum creatinine, the risk for hospitalization with myocardial infarction was two to five times higher in anemic (Hb <12 g/dl) patients than in people with Hb from 12.0 to 12.9 g/dl. A similar but less dramatic pattern of higher incidence of coronary revascularization was observed with lower Hb levels. Risks for hospitalization with congestive heart failure declined regularly with increasing Hb levels from a doubling of risk at Hb <10 g/dl to a 61% decrease at 15 g/dl, both relative to 12.0 to 12.9 g/dl. The risk for progression to dialysis was only slightly elevated (7 to 34%) in anemic patients. Anemia raises the risk for cardiovascular disease in patients with elevated serum creatinine.
Similar articles
- Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Go AS, et al. Circulation. 2006 Jun 13;113(23):2713-23. doi: 10.1161/CIRCULATIONAHA.105.577577. Epub 2006 Jun 5. Circulation. 2006. PMID: 16754803 - Anemia as independent predictor of major events in elderly patients with chronic angina.
Muzzarelli S, Pfisterer M; TIME Investigators. Muzzarelli S, et al. Am Heart J. 2006 Nov;152(5):991-6. doi: 10.1016/j.ahj.2006.06.014. Am Heart J. 2006. PMID: 17070178 - Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure.
Wexler D, Silverberg D, Sheps D, Blum M, Keren G, Iaina A, Schwartz D. Wexler D, et al. Int J Cardiol. 2004 Jul;96(1):79-87. doi: 10.1016/j.ijcard.2003.04.073. Int J Cardiol. 2004. PMID: 15203265 - [Regarding the optimal hemoglobin target range in renal anemia].
Maurin N. Maurin N. Med Klin (Munich). 2008 Sep 15;103(9):633-7. doi: 10.1007/s00063-008-1102-3. Epub 2008 Sep 24. Med Klin (Munich). 2008. PMID: 18813886 Review. German.
Cited by
- Roxadustat Versus Erythropoietin: The Comparison of Efficacy in Reversing Ventricular Remodeling in Dialysis Patients with Anaemia.
Wang MY, Liu XQ, Jiang TT, Liu WT, Huang Y, Huang YL, Jin FY, Zhao Q, Wu QY, Wang GH, Ruan XZ, Ma KL. Wang MY, et al. Int J Med Sci. 2024 Feb 12;21(4):703-713. doi: 10.7150/ijms.87870. eCollection 2024. Int J Med Sci. 2024. PMID: 38464833 Free PMC article. - Impact of Chronic Kidney Disease on Clinical Outcomes during Hospitalization and Five-Year Follow-Up after Coronary Artery Bypass Grafting.
Laimoud M, Alanazi MN, Maghirang MJ, Al-Mutlaq SM, Althibait S, Ghamry R, Qureshi R, Alanazi B, Alomran M, Bakheet Z, Al-Halees Z. Laimoud M, et al. Crit Care Res Pract. 2023 Sep 26;2023:9364913. doi: 10.1155/2023/9364913. eCollection 2023. Crit Care Res Pract. 2023. PMID: 37795473 Free PMC article. - Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.
Maruyama S, Kurasawa S, Hayashi T, Nangaku M, Narita I, Hirakata H, Tanabe K, Morita S, Tsubakihara Y, Imai E, Akizawa T; PREDICT Investigators. Maruyama S, et al. Clin Exp Nephrol. 2023 Sep;27(9):757-766. doi: 10.1007/s10157-023-02362-w. Epub 2023 Jun 8. Clin Exp Nephrol. 2023. PMID: 37289335 Free PMC article. Clinical Trial. - Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study.
Jin C, Zhang Y, Luo C, Ren Y, Ye B, Hu X, Li Y, Zhu B, He Q, Shao L. Jin C, et al. Transl Androl Urol. 2022 Nov;11(11):1568-1576. doi: 10.21037/tau-22-709. Transl Androl Urol. 2022. PMID: 36507485 Free PMC article. - Association between haemoglobin concentration and intradialytic hypotension in patients undergoing maintenance haemodialysis: a retrospective cohort study.
Hara T, Kasahara Y, Nakagawa T. Hara T, et al. BMJ Open. 2022 Aug 26;12(8):e064026. doi: 10.1136/bmjopen-2022-064026. BMJ Open. 2022. PMID: 36028275 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical